EAM Investors’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-60,804
Closed -$2.58M 353
2024
Q3
$2.58M Sell
60,804
-18,829
-24% -$798K 0.39% 130
2024
Q2
$3.21M Buy
+79,633
New +$3.32M 0.52% 103
2022
Q1
Sell
-15,321
Closed -$2.31M 389
2021
Q4
$2.31M Sell
15,321
-301
-2% -$40.6K 0.38% 90
2021
Q3
$1.86M Buy
+15,622
New +$1.72M 0.31% 136
2020
Q4
Sell
-11,738
Closed -$1.33M 388
2020
Q3
$1.33M Sell
11,738
-4,478
-28% -$470K 0.32% 139
2020
Q2
$1.6M Sell
16,216
-16,164
-50% -$1.29M 0.35% 139
2020
Q1
$2.08M Buy
+32,380
New +$2.27M 0.65% 52
2019
Q4
Sell
-35,808
Closed -$2.11M 315
2019
Q3
$2.11M Sell
35,808
-21,419
-37% -$1.37M 0.56% 51
2019
Q2
$3.69M Sell
57,227
-12,706
-18% -$820K 0.9% 7
2019
Q1
$4.44M Sell
69,933
-19,157
-22% -$1.01M 1.09% 4
2018
Q4
$3.38M Sell
89,090
-23,894
-21% -$844K 0.92% 7
2018
Q3
$4.84M Sell
112,984
-87,203
-44% -$3.05M 0.72% 14
2018
Q2
$4.41M Buy
+200,187
New +$2.46M 0.7% 15

Other funds holding TNDM

EAM Investors's TNDM Position: Q4 2024 in Review

EAM Investors sold out of Tandem Diabetes Care (TNDM) in Q4 2024, closing a stake of 60,804 shares — an estimated $2.58M sold.

EAM Investors first reported a position in TNDM in Q2 2018 and held it in 13 quarters. The position peaked at $4.84M in Q3 2018. 316 funds tracked by Wall St. Rank hold TNDM as of Q4 2024.

  • EAM Investors reported no remaining Tandem Diabetes Care position as of Q4 2024 after selling out during the quarter.
  • EAM Investors sold 60,804 Tandem Diabetes Care shares in Q4 2024, an estimated $2.58M.
  • EAM Investors first reported a position in Tandem Diabetes Care in Q2 2018 and held it in 13 quarters.
  • EAM Investors's Tandem Diabetes Care position peaked at $4.84M in Q3 2018.
  • 316 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2024.

Based on EAM Investors's 13F filing for Q4 2024, filed 13 Feb 2025.